NICE under increased pressure over conflicts of interest
October 22, 2014Sales and Marketing GPs, NHS, NICE, UK, baker, conflict, mccoll, wollaston
A group of influential doctors is calling on the government to tighten up NICE’s conflicts of interests policy. In a …
Epic Sciences hires chief information officer
October 22, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michael Giske, epic sciences
San Diego-based diagnostics development firm Epic Sciences has appointed Michael Giske as its chief information officer. Giske has more than …
Shire interim chief financial officer resigns
October 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Shire, james bowling, merger
Shire’s interim chief financial officer James Bowling has left the firm for water company Severn Trent following the collapse of …
Parkinson’s UK appoints research director
October 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arthur Roach, Parkinson's UK
Charity organisation Parkinson’s UK has appointed a leading pharma industry expert in Dr Arthur Roach as its research director. Roach …
AbbVie ditches Shire as tax deal falters
October 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Obama, Shire, US government, tax, tax inversion
Tax rule changes coming from the US government have forced the collapse of a multi-billion dollar deal between Humira manufacturer …
Medicine Innovation Bill a step closer in UK
October 20, 2014Sales and Marketing BBC, DH, NHS, innovation bill, saatchi
A new bill proposed by Conservative peer Lord Saatchi has been given government backing as it seeks to become law …
Admedus appoints two board directors
October 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John Seaberg, Wayne Paterson, admedus
Australian-based healthcare product development firm Admedus has appointed two new directors to its board. John Seaberg and Wayne Paterson (pictured) …
Pharmacists could save the NHS £1.1 billion
October 20, 2014Sales and Marketing GP, GPs, NHS, UK, pharmacists
New research from the Royal Pharmaceutical Society shows that common ailments such as coughs and sore throats cost the NHS …
Working Life: MedImmune’s Dr Bing Yao
October 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MedImmune, Working Life, bing yao
How did you find your way into your current role? When I was pursuing my doctorate in microbiology and immunology, …
GSK: Ebola vaccines will come ‘too late’
October 17, 2014Manufacturing and Production, Research and Development, Sales and Marketing Ebola, GSK, JK-05, Sihuan, tekmira, vaccines, zmapp
GlaxoSmithKline says its potential Ebola vaccine will come ‘too late’ for the current outbreak despite being fast-tracked. In August the …
Roche and Pharmacyclics agree leukaemia pact
October 17, 2014Research and Development, Sales and Marketing BMS, CLL, Cancer, Gazyva, Pharmacyclics, Roche, imbruvica, leukaemia
Pharmacyclics’s cancer drug Imbruvica will be tested in combination with Roche’s Gazyva in a new partnership announced by the firms. …
Woodley commemorates 25 years in the industry
October 17, 2014Manufacturing and Production, Sales and Marketing Manchester, Supply, development, manufacturing, wickham, woodley
Medical supplier firm Woodley celebrated its 25-year anniversary this month at a lavish event at The Runway Visitor Park in …
Mobile telehealth to create ‘doctor in your pocket’ convenience
October 17, 2014Medical Communications, Sales and Marketing frost and sullivan, health, telehealth, videoconferencing, wearables
The telehealth industry is on the verge of a dramatic growth surge that is significantly disrupting the healthcare sector in …
Novartis cancer drug beating path to NHS
October 17, 2014Sales and Marketing GIST, Glivec, NHS, NICE, imatinib, uturn
NICE has issued final draft guidance recommending Novartis’s Glivec for up to three years in people who have had a …
Four promotions at Red Door Communications
October 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kate Aldous, Katy Pogson, Matt Lowe, Red Door Communications, Sarah Aldridge
Red Door Communications (RDC) has promoted Matt Lowe and Katy Pogson to its board of directors, and Kate Aldous and …
New cancer drugs escalate Roche earnings
October 16, 2014Research and Development, Sales and Marketing Cancer, Herceptin (trastuzumab), Kadcyla, Perjeta, Q3, Roche, ado-trastuzumab emtansine, pertuzumab
Roche’s sales saw solid growth in the first nine months of the year, increased by the firm’s new cancer medicines. …
AstraZeneca deepens Cambridge ties
October 16, 2014Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, CRUK, Cambridge, MRC, MedImmune
AstraZeneca along with its biologics R&D arm MedImmune are to enter into four new collaborations with the University of Cambridge. …
Boehringer and Roche IPF drugs win FDA approval
October 16, 2014Research and Development, Sales and Marketing Boehringer, ERS, Esbriet, FDA, IPF, InterMune, Roche, US, lung scarring, lungs, ofev
The FDA has approved both Roche’s Esbriet (pirfenidone) and Boehringer Ingelheim’s Ofev (nintedanib) for the treatment of the fatal lung …
NICE not recommending Dendreon cancer vaccine
October 16, 2014Sales and Marketing Dendreon, NHS, NICE, Provenge, sipuleucel-T, therapeutic cancer vaccine
NICE has issued preliminary draft guidance not recommending Dendreon’s therapeutic cancer vaccine Provenge for prostate cancer in people whose disease …
Novo Nordisk hires human resources VP
October 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jackie Scanlan, Novo Nordisk
Novo Nordisk has appointed Jackie Scanlan to join its executive team as the corporate vice president of its human resources …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
